DenovAI Biotech

Pioneering accurate de novo protein design, building functional biologics entirely from scratch using artificial intelligence and computational biophysics.

Health Tech & Life Sciences
Active
Seed Rehovot, Israel Founded 2023
Last updated 2026-07-26
Total raised
$4.0M
Last: Undisclosed Round 2024-02
Stage
Seed
Founded
2023
Headcount
30
HQ
Rehovot, Israel
Sector
Health Tech & Life Sciences

About

DenovAI Biotech is an Israeli startup based in Rehovot, operating at the nexus of artificial intelligence and computational biophysics. The company is developing foundational technology platforms that can design proteins de novo (completely from scratch) to create next-generation therapeutics like high-affinity antibodies, small protein and peptide biologics, and diagnostic reporters. DenovAI's AI-based platform aims to accelerate the drug discovery process, reducing timelines from months to days and broadening the scope of therapy to many more diseases. They are a portfolio company of AION Labs, a venture hub backed by global pharma and technology leaders and investors.

Funding history · 2 rounds · $4.0M total

2024-01
Seed $3.0M
★ Amiti Ventures
2023-01
Pre-Seed $1.0M
★ AION LabsMerckAstraZenecaPfizer VenturesTeva Pharmaceuticals

Headcount over time

From 1 (2023-06) to 12 (2025-12) · +11 (+1100%) · 7 points · source: Finder history + radar grounding
120 2023-06 2025-12

Q&A

What is DenovAI Biotech's primary focus?
DenovAI Biotech focuses on pioneering accurate de novo protein design, building functional biologics entirely from scratch using artificial intelligence and computational biophysics.
When was DenovAI Biotech founded?
DenovAI Biotech was founded in 2023.
How many employees does DenovAI Biotech have?
DenovAI Biotech has 11-50 employees.
What is DenovAI Biotech's total funding to date?
DenovAI Biotech has raised a total of $4,000,000 USD.
Who is the Founder & CEO of DenovAI Biotech?
Kashif Sadiq is the Founder & CEO of DenovAI Biotech.
What sector does DenovAI Biotech primarily operate in?
DenovAI Biotech primarily operates in the Health Tech & Life Sciences sector.

Team · 1

Kashif Sadiq
Founder · Founder & CEO

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Technologies
Artificial IntelligenceBiologicalsMolecules
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticalsBiotechnology
Business model
B2B

Tags

pharmaceuticalsproteinsdiagnosticsartificial-intelligencebiotechnologyantibodies
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)

External links

Websitedenovai.com/
LinkedInlinkedin.com/company/93381246

Identifiers & details

Founded2023
Employees (exact)30

Radar intelligence

Web history (Wayback)

Domaindenovai.com

Israeli Companies Registrar (רשם החברות / ICA)

Registrar # (ח.פ.)516751294
Statusפעילה
Corp typeישראלית חברה פרטית
Incorporated2023-01-22
Purposeלעסוק בכל עיסוק חוקי
Liabilityמוגבלת
In violation (unfiled)no
Last annual report2026
Active charges / liens0
Registry events4 — annual_report (1), people (2), shares_capital (1)
Registered addressאופנהיימר 4 רחובות

Recent registry events

DateEvent
2026-01-13דו~ח שנתי-הקצאת מניות
2026-02-09עדכון דירקטורים-הוספת דירקטור
2026-01-07שינוי בהרכב הון - מניות-פיצול מניה
2026-01-05עדכון דירקטורים-הסרת דירקטור